Stockscreener 앱 받기
2.97
7.19%
-0.23
전일 마감가:
$3.20
열려 있는:
$2.99
하루 거래량:
481.88K
Relative Volume:
0.56
시가총액:
$1.43M
수익:
-
순이익/손실:
$-9.34M
주가수익비율:
-0.327
EPS:
-9.0833
순현금흐름:
$-6.69M
1주 성능:
+39.88%
1개월 성능:
-8.33%
6개월 성능:
-83.50%
1년 성능:
-94.24%
1일 변동 폭
$2.51
$3.14
1주일 범위
$2.044
$7.28
52주 변동 폭
$1.7272
$80.64
패인리폼 Stock (PRFX) Company Profile
PRFX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| PRFX | 2.97 | 1.43M | 0 | -9.34M | -6.69M | -9.0833 |
| ZTS | 176.96 | 79.73B | 9.15B | 2.43B | 2.31B | 4.92 |
| HLN | 9.65 | 43.70B | 14.26B | 1.55B | 0 | 0.3327 |
| TAK | 13.38 | 42.47B | 30.27B | 1.93B | 3.45B | 0.444 |
| TEVA | 17.12 | 19.40B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.37 | 15.88B | 15.05B | -883.30M | 1.89B | 1.53 |
패인리폼 주식(PRFX)의 최신 뉴스
3 Penny Stocks to Watch Now, 11/21/24 - TipRanks
Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results - Benzinga
Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views - Benzinga
US Stocks Mostly Lower; Target Posts Downbeat Earnings - Benzinga
PainReform’s PRF-110 Shows Promise in Initial Trial Results - TipRanks
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial - GlobeNewswire
PainReform's PRF-110 Shows Early Success in Phase 3 Pain Trial, Data Issues Persist | PRFX Stock News - StockTitan
"Stocks Under $1 to Watch: SOAR, PRFX, NCNC, BTTC, RJDG-Breakthroughs, Surges, Market Movers!" - openPR
Gold Moves Higher; Medtronic Posts Upbeat Results - Benzinga
PainReform Stock Is Soaring Tuesday: What's Going On? - Benzinga
Stock Market News: PainReform surges by 130.26% whereas QMMM Holdings declines by 28.03% during mid day trading - Business Upturn
Nasdaq Gains 100 Points; Lowe's Earnings Beat Views - Benzinga
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
PainReform Announces 1-for-4 Reverse Share Split - TipRanks
Armistice Capital, LLC's Strategic Acquisition in PainReform Ltd - GuruFocus.com
PainReform faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
PainReform receives Nasdaq notice regarding minimum stockholders’ equity requirement - MSN
PRFXPainReform Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
PainReform faces Nasdaq delisting over equity shortfall - Investing.com India
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement - GlobeNewswire
PRFX stock touches 52-week low at $0.53 amid sharp annual decline - Investing.com India
PainReform cut to Hold at Maxim amid ‘changed’ market dynamics - Yahoo Finance
Maxim cuts PainReform stock rating to Hold from Buy post FDA update - Investing.com India
Maxim cuts PainReform stock rating to Hold from Buy post FDA update By Investing.com - Investing.com South Africa
PainReform (NASDAQ:PRFX) Shares Up 11% – Here’s Why - Defense World
PainReform Announces Significant Share Offering - TipRanks
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
What You Didn’t Know About PainReform Ltd (NASDAQ: PRFX) This Week - Stocks Register
When Would Be The Best Time To Buy SBA Communications Corp (NASDAQ: SBAC) Stock? - Stocks Register
What You Didn’t Know About Crown Castle Inc (NYSE: CCI) This Week - Stocks Register
PainReform Calls Shareholder Meeting for Key Votes - TipRanks
PainReform Shareholders Approve All Proposals - TipRanks
Prestige Wealth Inc. (NASDAQ:PWM) Sees Significant Drop in Short Interest - Defense World
PainReform Ltd. (NASDAQ:PRFX) Short Interest Up 2,221.4% in September - Defense World
Insider’s View: Deciphering PainReform Ltd (PRFX)’s Financial Health Through Ratios - The Dwinnex
US Stocks Edge Higher; Chicago Fed National Activity Increases In August - Benzinga
PainReform Ltd (PRFX)’s results reveal risk - US Post News
Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
PainReform Ltd [PRFX] Is Currently 4.40 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
Was there any good news for PainReform Ltd (PRFX) stock in the last session? - US Post News
Navigating PRFX’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle
PRFX stock touches 52-week low at $0.74 amid sharp annual decline - Investing.com
Financial Health Check: Examining PainReform Ltd (PRFX)’s Key Ratios - The Dwinnex
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110 - GlobeNewswire
PainReform Ltd. Launches Warrant Exercise Incentive Program - TipRanks
PainReform confirms sutures compatibility for in trial for PRF-110 - TipRanks
Ratio Analysis: Unpacking PainReform Ltd (PRFX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
PainReform to issue new warrants in stock exercise deal By Investing.com - Investing.com Australia
패인리폼 (PRFX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
0.30%
자본화:
|
볼륨(24시간):